PARP1 and breast cancer: Although Cdh1 depletion had a negligible effect on the proliferation of breast cancer cell lines used in this study (Figure 2B), it can significantly potentiate the cytotoxic effects of PARP inhibitors on TNBC cells (Figure 2C).